JP2019509300A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509300A5
JP2019509300A5 JP2018549447A JP2018549447A JP2019509300A5 JP 2019509300 A5 JP2019509300 A5 JP 2019509300A5 JP 2018549447 A JP2018549447 A JP 2018549447A JP 2018549447 A JP2018549447 A JP 2018549447A JP 2019509300 A5 JP2019509300 A5 JP 2019509300A5
Authority
JP
Japan
Prior art keywords
vaccine
immunogen
pcv2
use according
mycoplasma hyopneumoniae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509300A (ja
JP6907227B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/056831 external-priority patent/WO2017162741A1/en
Publication of JP2019509300A publication Critical patent/JP2019509300A/ja
Publication of JP2019509300A5 publication Critical patent/JP2019509300A5/ja
Application granted granted Critical
Publication of JP6907227B2 publication Critical patent/JP6907227B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549447A 2016-03-23 2017-03-22 Pcv2ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン Expired - Fee Related JP6907227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161997.8 2016-03-23
EP16161997 2016-03-23
PCT/EP2017/056831 WO2017162741A1 (en) 2016-03-23 2017-03-22 A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection

Publications (3)

Publication Number Publication Date
JP2019509300A JP2019509300A (ja) 2019-04-04
JP2019509300A5 true JP2019509300A5 (cg-RX-API-DMAC10.html) 2020-03-12
JP6907227B2 JP6907227B2 (ja) 2021-07-21

Family

ID=55589754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549447A Expired - Fee Related JP6907227B2 (ja) 2016-03-23 2017-03-22 Pcv2ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン

Country Status (7)

Country Link
US (1) US20190105385A1 (cg-RX-API-DMAC10.html)
EP (1) EP3432919A1 (cg-RX-API-DMAC10.html)
JP (1) JP6907227B2 (cg-RX-API-DMAC10.html)
CN (1) CN108697782A (cg-RX-API-DMAC10.html)
BR (1) BR112018069100A2 (cg-RX-API-DMAC10.html)
RU (1) RU2018137034A (cg-RX-API-DMAC10.html)
WO (1) WO2017162741A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7354106B2 (ja) * 2017-12-04 2023-10-02 インターベット インターナショナル ベー. フェー. レプリコン粒子および油性アジュバントによるワクチン接種
CA3085535A1 (en) 2017-12-22 2019-06-27 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
CN114364398B (zh) * 2019-09-12 2025-08-22 英特维特国际股份有限公司 用于皮内施用的联合疫苗
EP4138892A1 (en) 2020-04-20 2023-03-01 Intervet International B.V. A vaccine to protect against mycoplasma hyopneumoniae
MX2022013080A (es) * 2020-04-20 2022-11-10 Intervet Int Bv Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
CN115887636B (zh) * 2022-01-18 2026-07-03 武汉科前生物股份有限公司 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法
AU2024402296A1 (en) 2023-12-19 2026-05-28 Intervet International B.V. Low-energy electron irradiation-inactivated mollicutes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
PL1651265T3 (pl) * 2003-07-24 2008-10-31 Merial Ltd Formulacje szczepionek zawierających emulsję olej w wodzie
KR20110132416A (ko) * 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
CA2587321A1 (en) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Improved prrs vaccines
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AR054822A1 (es) * 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
CA2635430A1 (en) 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
EP2753354A4 (en) * 2011-09-09 2015-04-15 Nanobio Corp SUB-VACCINE IN NANOEMULSION FORM FOR RESPIRATORY SYNZYTIAL VIRUS
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
CN103263666B (zh) * 2013-05-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法
WO2015082457A1 (en) * 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2

Similar Documents

Publication Publication Date Title
RU2018137034A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
JP2015512449A5 (cg-RX-API-DMAC10.html)
MX2007011268A (es) Composiciones inmunogeneticas que comprende lawsonia intracelularis.
WO2009126356A3 (en) Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
AR069216A1 (es) Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos
RU2019122996A (ru) Комбинированная вакцина для свиней
RU2017124240A (ru) СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo
JP2022548001A5 (cg-RX-API-DMAC10.html)
JP2023025210A5 (cg-RX-API-DMAC10.html)
RU2017101091A (ru) Композиции вакцин с двойным адъювантом, получение и применения
JP2025026461A5 (cg-RX-API-DMAC10.html)
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.
RU2018127403A (ru) Поливалентная вакцина против hyo и ее применение
TW201613638A (en) Antibody guided vaccines and methods of use for generation of rapid mature immune responses
RU2019136252A (ru) Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения
DK3076997T3 (en) SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
WO2018107083A3 (en) Virulent aeromonas vaccines and methods
JP2019512518A5 (cg-RX-API-DMAC10.html)
RU2022116197A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
JP2019509302A5 (cg-RX-API-DMAC10.html)
BR112014022067B1 (pt) Composição compreendendo antígeno e lipopolissacarídeo
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs